Quantcast

Latest Angiogenesis Stories

2014-04-15 08:31:02

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today presented highlights of financial results fiscal year ended December 31, 2013, and other recent developments. http://photos.prnewswire.com/prnvar/20140415/LA04094 Focus on Gene Therapy and Regenerative Medicine Biologics The Company recently announced that the U.S.-based Cardium Therapeutics operations will be primarily focused on the clinical and commercial development...

2014-04-01 13:57:22

Wounds may heal more quickly if exposed to low-intensity vibration, report researchers at the University of Illinois at Chicago. The finding, in mice, may hold promise for the 18 million Americans who have type 2 diabetes, and especially the quarter of them who will eventually suffer from foot ulcers. Their wounds tend to heal slowly and can become chronic or worsen rapidly. Timothy Koh, UIC professor of kinesiology and nutrition in the UIC College of Applied Health Sciences, was...

2014-03-26 08:29:46

TORONTO, March 26, 2014 /CNW/ - The Gairdner Foundation is pleased to announce the winners of the 2014 Canada Gairdner Awards, recognizing some of the most significant medical discoveries from around the world. This year's winners showcase a broad range of new medical discoveries related to cardiovascular disease, cancer, immunotherapy and human parasitic diseases. Among the world's most esteemed medical research prizes, the awards distinguish Canada as a leader in science and...

2014-03-04 12:25:51

SAN DIEGO and OSAKA, Japan, March 4, 2014 /PRNewswire/ -- TRACON Pharmaceuticals (TRACON) and Santen Pharmaceutical Co., Ltd. (Santen) announced today that they have entered into an exclusive agreement for the development and global commercialization of TRACON's anti-endoglin antibodies, including TRC105, in ophthalmology. Pre-clinical and clinical data from TRACON's ongoing development of TRC105 in combination with anti-VEGF products in oncology indicate inhibiting both the...

2014-02-26 12:25:25

BOCA RATON, Fla., Feb. 26, 2014 /PRNewswire/ -- Medical studies on the potential benefits of alkaline ionized drinking water have grown more numerous in recent years. One study titled, 'Inhibitory effect of electrolyzed reduced water on tumor angiogenesis' is a remarkable discovery which cancer patients should be aware of. The study reports these findings: "ERW (Electrolyzed reduced water) counteracted the effect of A549 cell-conditioned medium and decreased total tube length."...

2014-02-21 23:02:24

Okyanos Selects Cytori To Provide Equipment And Supplies To Treat Patients With Coronary Artery Disease Using Their Own Adult Stem Cells Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, and Cytori Therapeutics have announced that they have established a ten year supply agreement for the Celution™ System family of...

2014-02-20 23:00:05

The panel of presenters will discuss opportunities for medical industry start-ups in the Bahamas after recent stem cell research and Therapy Act Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, announces CEO Matt Feshbach will present at the STEMSO Conference. He will join a panel to discuss the opportunities...

2014-02-11 08:33:10

CAMBRIDGE, Mass., Feb. 11, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in an open label single-arm Phase 2 clinical trial of its lead candidate, CRLX101, in combination with Avastin (bevacizumab) in patients with relapsed ovarian cancer. The Phase 2 combination therapy trial of this investigational treatment is being conducted at Massachusetts General Hospital (MGH) and...

2014-01-28 23:03:54

An early stage study shows melatonin – a hormone that regulates the body’s sleep and awake cycles – may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of São Paulo. Detroit, Michigan (PRWEB) January 28, 2014 An early stage study shows melatonin – a hormone that regulates the body’s sleep and awake cycles – may have the potential to...

Melatonin Therapy May Help Slow Breast Cancer Tumor Growth
2014-01-28 14:19:25

Brett Smith for redOrbit.com - Your Universe Online Produced by the brain in response to darkness and often taken as a sleep aid supplement, melatonin could be effective in slowing the growth of certain breast cancer tumors, according to a new report published in the open-access journal PLOS ONE. More specifically, melatonin may stunt tumor growth and tumor cell production, as well as obstruct the generation of new blood vessels in breast cancer cells that test negative for estrogen...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related